ROBERT PETIT
CIK 1576077 · See Remarks · last filed 2026-02-13
ROBERT PETIT is a corporate insider who has filed 63 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing, for OSTX, was dated Feb 13, 2026. Across all open-market trades the lifetime net is −$208.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $340.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$340.0K
4
63
-$208.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OSTX | See Remarks | 200,000 | $1.70 | $340.0K | $0 | 2 | 2026-02-13 |
| Ayala Pharmaceuticals, Inc. (ADXS) Delisted | Chief Scientific Officer | 231,206 | $0.60 | $139.6K | -$7.1K | 2 | 2018-11-07 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Chief Scientific Officer | 243,660 | — | — | -$99.6K | 25 | 2018-08-01 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Chief Scientific Officer | 123,378 | — | — | -$102.0K | 34 | 2016-10-04 |
Recent Filings
63 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-13 | OSTX | Grant (A) | — | $0 | EDGAR |
| 2025-12-19 | OSTX | Grant (A) | — | $0 | EDGAR |
| 2018-11-07 | Ayala Pharmaceuticals, Inc. (ADXS) Delisted | Mixed | −3,963 | -$2.3K | EDGAR |
| 2018-11-05 | Ayala Pharmaceuticals, Inc. (ADXS) Delisted | Sell (S) | −8,491 | -$4.8K | EDGAR |
| 2018-08-01 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | +1,505 | $2.2K | EDGAR |
| 2018-07-02 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | +15,516 | $26.9K | EDGAR |
| 2018-06-01 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | +1,765 | $3.2K | EDGAR |
| 2018-05-02 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | +1,374 | $2.2K | EDGAR |
| 2018-04-03 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | −1,082 | -$1.7K | EDGAR |
| 2018-03-01 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | +1,182 | $2.2K | EDGAR |